
About Brichem Sciences
Brichem Sciences is a Healthcare company based in Ahmedabad (India) founded in 2020. Brichem Sciences produces API, hormones, and steroids for pharmaceutical industry. It operates on a B2B model. The company has 88 employees. Its Indian entity Brichem Sciences Private Limited reported revenue of βΉ91.35 Cr. Brichem Sciences offers products and services including Progesterone, Nandrolone, and API Hormones. Its focus areas include Pharmaceuticals, API Manufacturing, Steroids and Hormones. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Brichem Sciences Is A Gmp And Glp Approved Company Based In Gujarat, India, Specializing In Manufacturing Active Pharmaceutical Ingredients (apis) Such As Hormones And Steroids. They Focus On Delivering High-quality, Cost-effective Products Using Innovative Technology And Ensure Customer Satisfaction Through Ethical Practices. The Company Emphasizes Environmental Health, Safety, And Social Responsibility In Its Operations, Serving The Global Pharmaceutical Market With Consistent Quality And Reliable Supply.
- Headquarters Ahmedabad, India
- Employees 88
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website brichemsciences.com
- Legal Name Brichem Sciences Private Limited
- Date of Incorporation 05 Dec, 2016
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹91.35 Cr
FY 2025 · +16% YoY
- Net Profit₹7.67 Cr
FY 2025 · 8% margin
- EBITDA₹12.20 Cr
FY 2025 · 13% margin
- Employee Count88
Associated legal entities of Brichem Sciences
Brichem Sciences operates through Brichem Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Brichem Sciences Private Limited CIN U24304GJ2016PTC094569 | Active | 05 Dec 2016 | Ahmedabad, Gujarat | ₹91.3 Cr | 88 | 4 | View details |
Products & Services of Brichem Sciences
Brichem Sciences offers a comprehensive portfolio of products and services, including Progesterone, Nandrolone, and API Hormones.
Active ingredient used in hormone replacement therapies
Steroid compound for medical and therapeutic applications
General APIs focused on hormone production for health sectors
Board of directors of Brichem Sciences Private Limited (Brichem Sciences)
Brichem Sciences Private Limited is the primary company behind Brichem Sciences. The board of Brichem Sciences Private Limited currently have 4 directors; the longest-serving is Rajeshkumar Becharbhai Gami, appointed in 2016. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rajeshkumar Becharbhai Gami DIN 07657387 | Director | 05 Dec 2016 | 9 yrs 10 mo | Brichem Sciences Private Limited |
| Paragkumar Gunvantlal Bhavsar DIN 00844097 | Director | 23 Mar 2019 | 7 yrs 7 mo | Brichem Sciences Private Limited |
| Aashay Jayantilal Patel DIN 07986307 | Director | 31 Jul 2019 | 7 yrs 2 mo | Brichem Sciences Private Limited |
| Mittalkumar Jagdishbhai Patel DIN 07985748 | Director | 31 Jul 2019 | 7 yrs 2 mo | Brichem Sciences Private Limited |
Financials of Brichem Sciences
Figures of Brichem Sciences Private Limited, the primary company behind Brichem Sciences, for FY 2025. Revenue was ₹91.35 Cr (+16% year on year). Net profit was ₹7.67 Cr (8% margin). EBITDA was ₹12.20 Cr (13% margin). Revenue has grown at a compounded annual rate of +27% over three years and +52% over five years.
- ₹91.35 CrRevenue · FY 2025 · +16% YoY
- ₹7.67 CrNet profit · 8% margin
- ₹12.20 CrEBITDA · 13% margin
- ₹13.5 LakhPaid-up capital
- 88Employees (provident fund records)
- +27%Revenue CAGR, 3 years
- +52%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Brichem Sciences Private Limited are on its company page.
Detailed financial statements for Brichem Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Brichem Sciences
Brichem Sciences has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Brichem Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Brichem Sciences
Brichem Sciences was founded in 2020.
Brichem Sciences is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Brichem Sciences has 88 employees.
The primary company behind Brichem Sciences, Brichem Sciences Private Limited, reported revenue of βΉ91.35 Cr for FY 2025, up 16% year on year.
Brichem Sciences Is A Gmp And Glp Approved Company Based In Gujarat, India, Specializing In Manufacturing Active Pharmaceutical Ingredients (apis) Such As Hormones And Steroids. They Focus On Delivering High-quality, Cost-effective Products Using Innovative Technology And Ensure Customer Satisfaction Through Ethical Practices. The Company Emphasizes Environmental Health, Safety, And Social Responsibility In Its Operations, Serving The Global Pharmaceutical Market With Consistent Quality And Reliable Supply.
Brichem Sciences's top competitors include Laurus Labs, Symbiotec and SeQuent.
Brichem Sciences offers Progesterone, Nandrolone, and API Hormones.
Brichem Sciences operates through Brichem Sciences Private Limited.
The legal entities of Brichem Sciences currently have 4 directors, including Rajeshkumar Becharbhai Gami, Paragkumar Gunvantlal Bhavsar, Aashay Jayantilal Patel and others.